INDIA BUSINESS WORLD - NOVEMBER 16th - NOVEMBER 30th
- 2007
ORCHID GETS US FDA NOD FOR ANTIBIOTIC
Orchid Chemicals & Pharmaceuticals said it has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Cefpodoxime Proxetil Tablets. The product is available in two dosage strengths, 100 mg and 200 mg, it announced in BSE. Cefpodoxime Proxetil is a third-generation cephalosporin antibiotic which has a broad spectrum activity against organisms causing infectious diseases. With limited generic competition in this product, Orchid hopes to garner a sizeable market share and revenues in the US market, it added.
|